ID26509A - Komponen-komponen yang mengandung tetrahidrolipstatin - Google Patents

Komponen-komponen yang mengandung tetrahidrolipstatin

Info

Publication number
ID26509A
ID26509A IDW980113D ID980113D ID26509A ID 26509 A ID26509 A ID 26509A ID W980113 D IDW980113 D ID W980113D ID 980113 D ID980113 D ID 980113D ID 26509 A ID26509 A ID 26509A
Authority
ID
Indonesia
Prior art keywords
tetrahidrolipstatin
contain
components
contain tetrahidrolipstatin
Prior art date
Application number
IDW980113D
Other languages
English (en)
Inventor
Navnit Hargovindas Shah
Max Zeller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26671373&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID26509(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ID26509A publication Critical patent/ID26509A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
IDW980113D 1997-02-05 1998-01-24 Komponen-komponen yang mengandung tetrahidrolipstatin ID26509A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3738497P 1997-02-05 1997-02-05
US09/003,137 US6004996A (en) 1997-02-05 1998-01-06 Tetrahydrolipstatin containing compositions

Publications (1)

Publication Number Publication Date
ID26509A true ID26509A (id) 2001-01-11

Family

ID=26671373

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW980113D ID26509A (id) 1997-02-05 1998-01-24 Komponen-komponen yang mengandung tetrahidrolipstatin

Country Status (30)

Country Link
US (1) US6004996A (id)
EP (1) EP0921796B1 (id)
CN (1) CN1193752C (id)
AR (1) AR010704A1 (id)
AT (1) ATE200027T1 (id)
AU (1) AU713192B2 (id)
CA (1) CA2258095C (id)
CO (1) CO4920214A1 (id)
CY (1) CY2264B1 (id)
CZ (1) CZ287154B6 (id)
DE (1) DE69800639T2 (id)
DK (1) DK0921796T3 (id)
ES (1) ES2156028T3 (id)
GR (1) GR3036064T3 (id)
HK (1) HK1021313A1 (id)
HR (1) HRP980057B1 (id)
HU (1) HU225035B1 (id)
ID (1) ID26509A (id)
IL (1) IL126902A (id)
MA (1) MA24466A1 (id)
MY (1) MY118371A (id)
NO (1) NO320445B1 (id)
NZ (1) NZ332659A (id)
PE (1) PE57599A1 (id)
PT (1) PT921796E (id)
RU (1) RU2170579C2 (id)
SI (1) SI0921796T1 (id)
UY (1) UY24875A1 (id)
WO (1) WO1998034607A1 (id)
YU (1) YU49423B (id)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1017408B1 (en) * 1997-02-05 2005-04-13 F. Hoffmann-La Roche Ag Use of tethrahydrolipstatin in the treatment of diabetes type ii
PT1105122E (pt) * 1998-08-14 2005-08-31 Hoffmann La Roche Composicoes farmaceuticas que contem inibidores de lipase
AU745697B2 (en) * 1998-09-08 2002-03-28 Smithkline Beecham Corporation Lipstatin derivative-soluble fiber tablets
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
AR025609A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
EP1132389A1 (en) 2000-03-06 2001-09-12 Vernalis Research Limited New aza-indolyl derivatives for the treatment of obesity
DE10021618A1 (de) * 2000-05-04 2001-11-15 Volker Helmstaedter Präparat für Darmerkrankungen und dessen Verwendung
ES2269441T3 (es) * 2000-06-27 2007-04-01 F. Hoffmann-La Roche Ag Metodo para la preparacion de una composicion.
AU8969601A (en) * 2000-07-28 2002-02-13 Hoffmann La Roche New use of lipase inhibitors
CZ302087B6 (cs) * 2000-07-28 2010-10-06 F. Hoffmann-La Roche Ag Farmaceutický prípravek obsahující orlistat spolu se sekvestrantem žlucových kyselin pro použití pro lécení a prevenci obezity
CA2417607C (en) 2000-08-09 2008-01-29 Christine Feinle Lipase inhibitors for the treatment of dyspepsia
US6900226B2 (en) 2000-09-06 2005-05-31 Hoffman-La Roche Inc. Neuropeptide Y antagonists
MXPA03003246A (es) 2000-10-16 2003-06-06 Hoffmann La Roche Derivados de indolina y su uso como ligandos del receptor 5-ht2.
GB0030710D0 (en) * 2000-12-15 2001-01-31 Hoffmann La Roche Piperazine derivatives
CA2432085C (en) 2000-12-27 2009-02-24 F. Hoffmann-La Roche Ag Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
GB0106177D0 (en) * 2001-03-13 2001-05-02 Hoffmann La Roche Piperazine derivatives
KR100621287B1 (ko) 2001-05-21 2006-09-13 에프. 호프만-라 로슈 아게 신경 펩타이드 ｙ 수용체에 대한 리간드로서의 퀴놀린유도체
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
US6787558B2 (en) * 2001-09-28 2004-09-07 Hoffmann-La Roche Inc. Quinoline derivatives
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20050003001A1 (en) * 2001-11-07 2005-01-06 Hisami Yamaguchi Method for improving dissolution of poorly dispersible medicaments
CA2470859A1 (en) * 2001-12-20 2003-07-03 Alpex Pharma Sa Pharmaceutical composition comprising skim milk powder
GB0202015D0 (en) * 2002-01-29 2002-03-13 Hoffmann La Roche Piperazine Derivatives
WO2003066055A1 (en) * 2002-02-04 2003-08-14 F. Hoffmann-La Roche Ag Quinoline derivatives as npy antagonists
MXPA04008379A (es) 2002-02-28 2004-11-26 Hoffmann La Roche Derivados de tiazol como antagonistas del receptor de neuropeptido y (npy).
JP4234017B2 (ja) * 2002-04-26 2009-03-04 エフ．ホフマン−ラ ロシュ アーゲー リパーゼ阻害薬及びグルコマンナンを含む医薬組成物
PL374817A1 (en) * 2002-07-05 2005-10-31 F.Hoffmann-La Roche Ag Quinazoline derivatives
CN100381429C (zh) * 2002-08-07 2008-04-16 霍夫曼-拉罗奇有限公司 噻唑衍生物
CA2494601C (en) * 2002-09-12 2009-09-29 F. Hoffmann-La Roche Ag N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
MXPA05005445A (es) * 2002-11-25 2005-08-26 Hoffmann La Roche Derivados de indolilo.
US20040178058A1 (en) * 2003-03-10 2004-09-16 Hsueh-Chung Chen Electro-chemical deposition apparatus and method of preventing cavities in an ECD copper film
GB0314967D0 (en) * 2003-06-26 2003-07-30 Hoffmann La Roche Piperazine derivatives
BRPI0413500A (pt) * 2003-08-12 2006-10-10 Hoffmann La Roche compostos, processos para a sua preparação, composição farmacêutica que compreende os mesmos, utilização de um composto, métodos para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade
WO2005014593A1 (en) * 2003-08-12 2005-02-17 F. Hoffmann-La Roche Ag Thiazole derivatives as npy antagonists
US20060246141A1 (en) * 2005-04-12 2006-11-02 Elan Pharma International, Limited Nanoparticulate lipase inhibitor formulations
CA2609634C (en) * 2005-05-03 2011-02-01 F. Hoffmann-La Roche Ag Tetracyclic azapyrazinoindolines as 5-ht2 ligands
KR100910000B1 (ko) * 2005-05-13 2009-07-29 씨제이제일제당 (주) 리파아제 저해제 함유 약학 조성물
WO2006132440A1 (ja) * 2005-06-09 2006-12-14 Takeda Pharmaceutical Company Limited 固形製剤
CA2618568A1 (en) * 2005-08-18 2007-02-22 F. Hoffmann-La Roche Ag Thiazolyl piperidine derivatives useful as h3 receptor modulators
US20070092577A1 (en) * 2005-10-03 2007-04-26 University Of Tennessee Research Foundation Dietary calcium for reducing the production of reactive oxygen species
KR101047204B1 (ko) * 2005-11-30 2011-07-06 에프. 호프만-라 로슈 아게 Ｈ3 조절제로서 사용하기 위한1,1-다이옥소-싸이오모폴린일 인돌일 메탄온 유도체
ES2359739T3 (es) * 2005-11-30 2011-05-26 F. Hoffmann-La Roche Ag Derivados de indol-2-il-amida 1,5-sustituida.
CA2630270A1 (en) * 2005-11-30 2007-06-07 F. Hoffmann-La Roche Ag 5-substituted indole-2-carboxamide derivatives
ES2333672T3 (es) * 2005-12-09 2010-02-25 F. Hoffmann-La Roche Ag Derivados de amida triciclica para tratamiento de obesidad.
ATE449776T1 (de) * 2005-12-15 2009-12-15 Hoffmann La Roche Pyrroloä2,3-cüpyridinderivate
ATE467632T1 (de) * 2005-12-16 2010-05-15 Hoffmann La Roche Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
EP1803714A1 (en) * 2005-12-27 2007-07-04 KRKA, tovarna zdravil, d.d., Novo mesto Process for preparing crystalline forms of orlistat
BRPI0707916A2 (pt) * 2006-01-13 2011-05-17 Hoffmann La Roche compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem e uso destes compostos
JP5031771B2 (ja) * 2006-01-23 2012-09-26 エフ．ホフマン−ラ ロシュ アーゲー Ｈ３受容体活性を有するシクロヘキシルスルホンアミド誘導体
US7432255B2 (en) * 2006-05-16 2008-10-07 Hoffmann-La Roche Inc. 1H-indol-5-yl-piperazin-1-yl-methanone derivatives
JP2009538859A (ja) * 2006-05-30 2009-11-12 エフ．ホフマン−ラ ロシュ アーゲー ピペリジニルピリミジン誘導体
EP1872777A1 (en) * 2006-06-27 2008-01-02 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising tetrahydrolipstatin
US7514433B2 (en) 2006-08-03 2009-04-07 Hoffmann-La Roche Inc. 1H-indole-6-yl-piperazin-1-yl-methanone derivatives
US20080146559A1 (en) 2006-12-08 2008-06-19 Li Chen 4,5,6,7-Tetrahydro-Thieno [2,3-C] Pyridine Derivatives
TR200607613A2 (tr) * 2006-12-29 2008-07-21 NOBEL İLAÇ SAN.ve TiC.A.Ş. Lipaz inhibitörü içeren farmasötik formülasyonlar
EP2002825B1 (en) * 2007-06-14 2013-05-22 Krka Pharmaceutical compositions comprising orlistat
WO2009039157A2 (en) * 2007-09-17 2009-03-26 Dr. Reddy's Laboratories Ltd. Orlistat pharmaceutical formulations
WO2009044380A2 (en) 2007-10-05 2009-04-09 Ranbaxy Laboratories Limited Formulations containing orlistat particles having controlled particle size
US20100317642A1 (en) * 2007-10-15 2010-12-16 Inventis Dds Pvt Limited Pharmaceutical composition of orlistat
US8298583B2 (en) 2007-10-19 2012-10-30 Monosol Rx, Llc Film delivery system for tetrahydrolipstatin
US20090220593A1 (en) * 2008-01-29 2009-09-03 Gulati Inder Extended release dosage forms of quetiapine
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
US8309107B2 (en) * 2008-10-06 2012-11-13 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
BRPI0901602B8 (pt) 2009-04-03 2021-05-25 Ems S/A formulação farmacêuticas
MX342962B (es) 2009-09-18 2016-06-07 Teva Pharmaceuticals Holdings Mexico S A De C V Composicion farmaceutica para bajar de peso y procedimiento para obtener la misma.
UA107369C2 (en) * 2010-02-01 2014-12-25 Lab Bago S A Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process
US20120039999A1 (en) 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120040008A1 (en) 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
RU2566262C2 (ru) * 2011-06-15 2015-10-20 Синтон Бв Стабилизированная композиция вориконазола
AU2012284267B2 (en) 2011-07-15 2017-06-29 Nusirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
CN102362863B (zh) * 2011-11-21 2013-06-12 山东新时代药业有限公司 一种含奥利司他的制剂及其制备方法
WO2013092786A1 (en) 2011-12-23 2013-06-27 Norgine B.V. Compositions comprising cetilistat
NL2009995C2 (en) * 2011-12-23 2013-09-18 Norgine Bv Compositions.
GB201122213D0 (en) * 2011-12-23 2012-02-01 Norgine Bv Compositions
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
CN104203258A (zh) * 2012-03-13 2014-12-10 皮拉莫企业有限公司 用于治疗代谢紊乱的草药组合物
CN108452311A (zh) 2012-11-13 2018-08-28 纽斯尔特科学公司 用于增强能量代谢的组合物和方法
DE202012104963U1 (de) 2012-12-19 2013-01-14 Norgine B.V. Cetilistat aufweisende Zusammensetzungen
SG11201507046UA (en) 2013-03-15 2015-10-29 Nusirt Sciences Inc Leucine and nicotinic acid reduces lipid levels
CN104740637A (zh) * 2013-12-31 2015-07-01 北京科信必成医药科技发展有限公司 一种稳定的奥利司他口服制剂及其制备方法
KR20160119863A (ko) 2014-02-27 2016-10-14 뉴서트 사이언시스, 인크. 간 지방증의 감소 또는 예방을 위한 조성물 및 방법
US10743813B2 (en) 2014-09-11 2020-08-18 Rattan Nath Diabetes control using postprandial feedback
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
BR112018072539A2 (pt) 2016-05-05 2019-03-26 Aquestive Therapeutics, Inc. composições de epinefrina de administração aumentada
CN108785272B (zh) * 2018-09-04 2019-04-09 中山万汉制药有限公司 一种奥利司他软胶囊及其制备方法
CN115105476B (zh) * 2021-03-23 2023-11-14 山东新时代药业有限公司 一种奥利司他冻干口服制剂及其制备工艺
CN115300479A (zh) * 2022-08-23 2022-11-08 宁波高新区美诺华医药创新研究院有限公司 奥利司他胶囊制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
JPH04198129A (ja) * 1990-11-28 1992-07-17 Sumitomo Pharmaceut Co Ltd 活性型ビタミンｄ↓３類含有組成物
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor

Also Published As

Publication number Publication date
RU2170579C2 (ru) 2001-07-20
NO985337D0 (no) 1998-11-16
HU225035B1 (en) 2006-05-29
PT921796E (pt) 2001-09-28
EP0921796B1 (en) 2001-03-28
NO320445B1 (no) 2005-12-05
DK0921796T3 (da) 2001-07-16
CN1193752C (zh) 2005-03-23
US6004996A (en) 1999-12-21
NO985337L (no) 1998-11-16
HUP0001468A3 (en) 2000-12-28
WO1998034607A1 (en) 1998-08-13
UY24875A1 (es) 2000-12-29
CA2258095A1 (en) 1998-08-13
NZ332659A (en) 2000-03-27
AU6097298A (en) 1998-08-26
CN1220600A (zh) 1999-06-23
ES2156028T3 (es) 2001-06-01
CA2258095C (en) 2000-02-22
EP0921796A1 (en) 1999-06-16
MY118371A (en) 2004-10-30
MA24466A1 (fr) 1998-10-01
ATE200027T1 (de) 2001-04-15
PL330972A1 (en) 1999-06-21
HRP980057A2 (en) 1998-12-31
PE57599A1 (es) 1999-06-11
CZ287154B6 (en) 2000-09-13
GR3036064T3 (en) 2001-09-28
HU0001468D0 (en) 2000-05-28
YU49698A (sh) 1999-09-27
YU49423B (sh) 2006-01-16
HRP980057B1 (en) 2001-08-31
AU713192B2 (en) 1999-11-25
DE69800639D1 (de) 2001-05-03
DE69800639T2 (de) 2001-10-31
HUP0001468A2 (hu) 2000-09-28
CO4920214A1 (es) 2000-05-29
CY2264B1 (en) 2003-07-04
IL126902A0 (en) 1999-09-22
SI0921796T1 (en) 2001-06-30
HK1021313A1 (en) 2000-06-09
AR010704A1 (es) 2000-06-28
IL126902A (en) 2002-12-01
CZ352898A3 (cs) 1999-02-17

Similar Documents

Publication Publication Date Title
ID26509A (id) Komponen-komponen yang mengandung tetrahidrolipstatin
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
DK0970584T3 (da) Videokonferencesystem
ID23494A (id) Benda-benda penyerap yang mempunyai komponen-komponen yang dapat diambil
DE19810476B4 (de) Laryngomaske
FI972979A0 (fi) Kopplingsarrangemang
DE69810944T2 (de) Hydroperoxidzersetzungsverfahren
ID26317A (id) Formulasi pelepasan yang diperpanjang
ID21770A (id) Plester yang mengandung felbinak
DE69733411D1 (de) Störisolierungsschaltung
FR2759242B1 (fr) Logement
DE69806538T2 (de) Reifenvulkanisierungsformwerk
DE69831108D1 (de) Drehgeschwindigkeitsaufnehmer
DE29718724U1 (de) Bauelemente-Verbindung
ID23429A (id) Komposisi-komposisi sertralina yang larut
NO993633D0 (no) 5-Aroylnaftalen-Derivater
ID19844A (id) Komponen tumbukan
DE29810236U1 (de) Bauelement
DE29714074U1 (de) Bauelement
DE59704877D1 (de) Mikrogalvanisch hergestelltes bauteil
ATE296493T1 (de) Gehäuse
DE29703223U1 (de) Bereitschaftstasche
DE29710194U1 (de) Etui
DK1021192T3 (da) Dexamethason-gel
DE29809255U1 (de) Bauteil